NDC 79802-200

Rezurock

Belumosudil

Rezurock is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Kadmon Pharmaceuticals, Llc. The primary component is Belumosudil.

• Product ID: 79802-200_102e4ef4-7f84-4e34-8df1-479c24d1575d
• NDC: 79802-200
• Product Type: Human Prescription Drug
• Proprietary Name: Rezurock
• Generic Name: Belumosudil
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2021-07-16
• Marketing Category: NDA /
• Application Number: NDA214783
• Labeler Name: Kadmon Pharmaceuticals, LLC
• Substance Name: BELUMOSUDIL
• Active Ingredient Strength: 200 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2022-12-31

Packaging

NDC 79802-200-30

1 BOTTLE in 1 CARTON (79802-200-30) > 30 TABLET in 1 BOTTLE

• Marketing Start Date: 2021-07-16
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details